| dbo:description
|
- Geschäftsbetrieb in Kanada (de)
- Geschäftsbetrieb in Kanada (de)
|
| dbo:foundingYear
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageWikiLink
| |
| dbp:foundation
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Matt Coffey - President, and Chief Executive Officer, Chief Operating Officer; Kirk Look - Chief Financial Officer; Andres A. Gutierrez - Chief Medical Officer; Andrew de Guttadauro, President, Oncolytics Biotech Inc. (en)
|
| dbp:locationCity
| |
| dbp:locationCountry
| |
| dbp:name
|
- Oncolytics Biotech Inc. (en)
|
| dbp:products
|
- REOLYSIN, a first-in-class intravenously delivered immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. (en)
|
| dbp:tradedAs
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dct:subject
| |
| rdf:type
| |
| rdfs:label
| |
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Oncolytics Biotech Inc. (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
